Viking Therapeutics IncLatest Viking Therapeutics Inc News and UpdatesCompany & Industry OverviewsNASH Opportunity Driving Growth for Viking Therapeutics in 2018On October 8, Viking Therapeutics announced positive data from its in vivo study evaluating VK2809 in glycogen storage disease type la (or GDS la) indication.
Company & Industry OverviewsNASH Opportunity Driving Growth for Viking Therapeutics in 2018On October 8, Viking Therapeutics announced positive data from its in vivo study evaluating VK2809 in glycogen storage disease type la (or GDS la) indication.
